Brentuximab a novel antibody therapy: real‐world use confirms efficacy and tolerability for CD30‐positive cutaneous lymphoma. (1st March 2020)

Record Type:: Journal Article
Title:: Brentuximab a novel antibody therapy: real‐world use confirms efficacy and tolerability for CD30‐positive cutaneous lymphoma. (1st March 2020)
Main Title:: Brentuximab a novel antibody therapy: real‐world use confirms efficacy and tolerability for CD30‐positive cutaneous lymphoma
Authors:: Engelina, S.
Saggu, M.
Yoo, J.
Shah, F.
Stevens, A.
Irwin, C.
Chaganti, S.
Scarisbrick, J.J.
Abstract:
Is Part Of:: British journal of dermatology. Volume 182:Number 3(2020)
Journal:: British journal of dermatology
Issue:: Volume 182:Number 3(2020)
Issue Display:: Volume 182, Issue 3 (2020)
Year:: 2020
Volume:: 182
Issue:: 3
Issue Sort Value:: 2020-0182-0003-0000
Page Start:: 799
Page End:: 800
Publication Date:: 2020-03-01
Subjects:: Dermatology -- Periodicals
Skin -- Diseases -- Periodicals
616.5
Journal URLs:: http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2133 ↗
https://academic.oup.com/bjd ↗
http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1111/bjd.18535 ↗
Languages:: English
ISSNs:: 0007-0963
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 2307.400000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 24767.xml